(LDL)". According to these Nobel laureates and many other scientists, lowering LDL (often called "bad cholesterol" as opposed to high density lipoprotein which is called "good cholesterol") is essential for eliminating coronary heart disease [6] . There are, however, some scientists who strongly dispute the cholesterol hypothesis and argue against the use of cholesterol lowering drugs [8] . Due to the media attention given to heated debates between scientists who are supporters and opponents of the cholesterol hypothesis [1] , the public are often left confused about who to believe. Debate between scientists is certainly necessary to establish the truth but more effort could be made to establish joint research projects that bring together opponents and supporters of the cholesterol hypothesis to address key areas of con-
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flict. This will provide a positive image of the scientific community to the general public by showing that scientists, with differing views, can unite and work together. Such co-operation may also result in a better understanding of the role of cholesterol in health and disease by combining the skills and expertise of leading researchers in the field. Refraining from establishing such types of joint projects could potentially have serious implications for public health since people will continue to be in a dilemma as to if they should or should not lower their cholesterol levels.
Although 200 years has passed since cholesterol was named by Michel-Eugène Chevreul, it continues to intrigue scientists and non-scientists alike. There is no doubt that much more work needs to be done before we can fully understand the role of this small, but fascinating, molecule in life and death. Progress in this area requires interdisciplinary research and greater collaboration between scientists.
